I believe the European financial market contains too much risk, and one should rather invest in the American financial system because it has a lot more upward potential. I wrote that in one of my latest articles. However, there is one exception to my statement: UBS Group (NYSE:UBS). The Swiss banking group is especially strong in investment banking and asset management and will probably outperform the sector this year.
Why UBS is the exception
There are numerous reasons as to why I believe UBS Group has more potential than the rest of the European banking sector. Firstly, UBS has some making up to do in stock price. The European financial sector declined -3.7% over the last 12 months, while UBS Group declined even further to -13.36%. The main reason behind this steeper-than-average drop is the company missing its earnings in the first quarter of 2016. Ever since, their stock price has not recovered as fast as the rest of the market. This has led us to believe that UBS is slightly undervalued in comparison with the sector.
Top 10 Undervalued Stocks To Watch Right Now: LinkedIn Corporation(LNKD)
- [By Lisa Levin]
In trading on Friday, technology shares tumbled by 3.35 percent. Meanwhile, top losers in the sector included LinkedIn Corp (NYSE: LNKD), down 42 percent, and Sierra Wireless, Inc. (USA) (NASDAQ: SWIR), down 24 percent.
- [By Andres Cardenal]
The most powerful investment ideas are the ones that can be easily explained and understood. LinkedIn(LNKD) is an undisputed market leader in remarkably promising areas such as professional networking and online employment opportunities, and this makes the company a top name to buy in 2016 and hold for years to come.As of the third quarter of 2015, LinkedIn(LNKD) had 396 million registered members around the world, a big increase of 20% versus the same quarter the previous year, and 39,726 corporate solutions customers on the platform, a year-over-year increase of 31%. Individuals and corporations attract each other to LinkedIn in search of opportunities, and this creates a virtuous cycle driving sustainable growth over the long term.
Management is also translating the company’s massive opportunities into rapid revenue growth. Total sales grew 37% to $780 million last quarter, with the acquisition of online learning platform lynda.com representing $41 million of that. LinkedIn’s three growth engines are firing on all cylinders: Talent solutions for corporations grew 46%, while premium subscription sales increased 21%, and online advertising revenue jumped 28%.
LinkedIn(LNKD) is actively investing for growth, so profit margins are hard to predict in the short term. However, the company should be able to combine solid revenue growth and expanding profit margins in the years ahead.
- [By William White]
Shaich is living on the food-stamp budget as part of the SNAP challenge. SNAP is the system that replaced food stamps. Shaich started the challenge on Saturday and is documenting his challenge on LinkedIn (LNKD). Shaich took his $31.50, the average weekly budget for someone on SNAP, to a grocery store and boughtcereal, pasta, lentils, chickpeas and some vegetables. He noted that it was a barren shopping cart and that he didn’t know if he would be able to sustain himself on the budget. Shiach spent$25.95 on the food he bought that day, which leaves him with $5.55 to buy food with for the rest of the week, reports Daily Finance.
Top 10 Undervalued Stocks To Watch Right Now: Google Inc.(GOOG)
- [By Igor Novgorodtsev]
Perion used to be called Incredimail, a "freemium" flagship e-mail application. Several years ago, it drastically changed its business model from trying to upgrade its existing customers to a paid application to installing an Incredimail toolbar and changing browser search to MyStart which was running on top with Google (GOOG) search but displayed additional "sponsored" links. In the last two years, Perion has been very busy buying two privately held companies Sweetpacks and Smilebox, which also made "freemium" applications and converting them to the same business model.
- [By Yasin Ebrahim]
Since president-elect Donald Trumps surprise election victory, large-cap technology stocks such as Apple (NSDQ:AAPL), Alphabet Inc-C (NSDQ:GOOG) and Microsoft (NSDQ:MSFT) are in a period of consolidation as many fear that Trumps tough stance against tech companies could play out in the months to come. During the campaign trail, he hinted that he could reign in international trade agreements, limit the scope of net neutrality and tighten immigration policy for skilled tech workers, which would prove a drag on the earnings potential of large-cap technology companies like Microsoft.
- [By Chris Neiger]
For the mobile side, Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google has already released several iterations of its Cardboard headset, and recently released its new Daydream View headset. These allow users to use their own smartphones to power a VR device.
- [By Nick Taborek]
The Dows price-weighting system has proven a barrier to inclusion for some of Americas most-heavily traded technology stocks. Apple Inc. (AAPL) and Google Inc. (GOOG), which change hands above $500, have been left out. At the same time, the three companies to be removed had the lowest prices in the average.
- [By Benedict Evans]
Google (GOOG), of course, is trying to address the fragmentation embodied in these charts with a shift to Google Play services, as neatly explained by Ars Technica here. But though this means Google itself is less subject to fragmentation, it isn’t much help to a developer wondering whether to use APIs that are only in Android 4.2 or later – let alone one wondering why the app crashes on one Android 4.2 phone but not another.
- [By Rich Smith]
So what’s the upshot for SpaceX for investors who hope to one day invest in its IPO, and for investors who already, today, own a piece of SpaceX through their investment in Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) stock? Simply put, the documents theJournalunearthed show that SpaceX is not nearly as profitable an operation as we once believed it to be..
Top 10 Undervalued Stocks To Watch Right Now: Evoke Pharma, Inc.(EVOK)
- [By Cameron Saucier]
Evoke (Nasdaq: EVOK) is a pharmaceutical company that develops drug candidates intended to treat gastrointestinal diseases. EVOK rose 73% last month after it announced positive guidance from the FDA for Gimoti, a patented nasal delivery drug that is intended to treat gastroparesis in adult women. The positive results were from a second pre-NDA (New Drug Application) meeting Evoke had with the FDA. EVOK is currently trading at $2.67 per share and is down 9.83% as of Jan. 9 YOY.
Top 10 Undervalued Stocks To Watch Right Now: MINDBODY, Inc.(MB)
- [By Peter Graham]
The Q3 2016 earnings report for small cap online wellness services stock MINDBODY Inc (NASDAQ: MB) is scheduled for after the market closes onWednesday (October 26th). MINDBODY Inc along withmid cap fitnessdevice stockFitbit Inc (NYSE: FIT) and small cap fitness center operator Planet Fitness Inc (NYSE: PLNT)allhad IPOsin the summer of 2015 raisingtalk of a fitness stock bubble brewing.
Top 10 Undervalued Stocks To Watch Right Now: Ameresco, Inc.(AMRC)
- [By Manikandan Raman]
There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).
Top 10 Undervalued Stocks To Watch Right Now: CareTrust REIT, Inc.(CTRE)
- [By Monica Gerson]
Caretrust REIT Inc (NASDAQ: CTRE) is estimated to post its quarterly earnings at $0.26 per share on revenue of $22.21 million.
China Lodging Group, Ltd (ADR) (NASDAQ: HTHT) is projected to post its quarterly earnings at $0.41 per share on revenue of $1.39 billion.
Top 10 Undervalued Stocks To Watch Right Now: LCA-Vision Inc.(LCAV)
- [By Lisa Levin]
Medical Practitioners: This industry jumped 2.82% by 10:15 am. The top performer in this industry was LCA-Vision (NASDAQ: LCAV), which rose 2.9%. LCA-Vision’s trailing-twelve-month revenue is $91.12 million.
Top 10 Undervalued Stocks To Watch Right Now: Comp En De Mn Cemig ADS(CIG)
- [By Lisa Levin]
In trading on Friday, utilities shares fell by 0.33 percent. Meanwhile, top losers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), down 3 percent, and Companhia Paranaense de Energia (ADR) (NYSE: ELP), down 3 percent.
- [By Jim Robertson]
Yesterday, our Under the Radar Moversnewsletter suggestedgoing long on mid cap Brazilian utility stockCompanhia Energetica Minas Gerais (NYSE: CIG):
Top 10 Undervalued Stocks To Watch Right Now: Olympic Steel Inc.(ZEUS)
- [By Lisa Levin]
Basic materials shares gained around 1.89 percent in trading on Tuesday. Meanwhile, top gainers in the sector included Olympic Steel, Inc. (NASDAQ: ZEUS), and Mechel PAO (ADR) (NYSE: MTL).
- [By Lisa Levin]
Olympic Steel, Inc. (NASDAQ: ZEUS) was down, falling around 17 percent to $21.32. KeyBanc downgraded Olympic Steel from Sector Weight to Underweight.
- [By Joel Elconin]
Olympic Steel, Inc. (NASDAQ: ZEUS) is staging the biggest rally of the three off its upgrade. The lightly-traded issue jumped from its Friday close of $18.49 to $19.86 before falling back to the $19.50 area.
Top 10 Undervalued Stocks To Watch Right Now: Nu Skin Enterprises Inc.(NUS)
- [By Scott Rubin]
Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.
- [By Roberto Pedone]
Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.
Monday’s Volume: 2 million
Three-Month Average Volume: 900,802
Volume % Change: 85%
From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.
Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.
- [By Ben Levisohn]
Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:
“Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…
Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.
Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.
Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.
- [By William White]